Estadístiques de Palbociclib rechallenge for hormone receptor-positive/HER-negative advanced breast cancer: findings from the phase II BioPER trial
Visites totals
| views | |
|---|---|
| Palbociclib rechallenge for hormone receptor-positive/HER-negative advanced breast cancer: findings from the phase II BioPER trial | 100 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 1 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| albanell-ccr-palb.pdf | 34 |
| albanell-ccr-palb.pdf(legacy) | 15 |
Vistes principals per país
| views | |
|---|---|
| United States | 56 |
| Spain | 14 |
| Netherlands | 8 |
| Australia | 4 |
| Belgium | 3 |
| Ireland | 2 |
| India | 2 |
| Japan | 2 |
| Mongolia | 2 |
| China | 1 |
| Germany | 1 |
| Malaysia | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Boardman | 11 |
| Barcelona | 8 |
| Fairfield | 6 |
| Ann Arbor | 5 |
| Menlo Park | 5 |
| San Ramon | 5 |
| Redmond | 3 |
| Sacramento | 3 |
| Cambridge | 2 |
| Dublin | 2 |
| Madrid | 2 |
| Redwood City | 2 |
| Sükhbaatar | 2 |
| Trazo | 2 |
| Almería | 1 |
| Ashburn | 1 |
| Bartlesville | 1 |
| Cedar Creek | 1 |
| Durham | 1 |
| Erlangen | 1 |
| Indianapolis | 1 |
| Las Vegas | 1 |
| Los Vargas | 1 |
| Maryborough | 1 |
| New York | 1 |
| Phoenix | 1 |
| Seattle | 1 |
| Shah Alam | 1 |
| Somerville | 1 |
| Thane | 1 |
| Woodbridge | 1 |